Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1970 1
1971 1
1972 1
1973 2
1974 1
1975 1
1977 4
1978 1
1979 3
1983 3
1984 1
1985 2
1986 4
1987 13
1988 8
1989 4
1990 8
1991 9
1992 7
1993 17
1994 18
1995 17
1996 27
1997 22
1998 18
1999 18
2000 11
2001 15
2002 19
2003 10
2004 18
2005 25
2006 31
2007 20
2008 20
2009 38
2010 28
2011 29
2012 29
2013 31
2014 28
2015 30
2016 32
2017 30
2018 17
2019 15
2020 7
2021 6
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

655 results
Results by year
Filters applied: . Clear all
Page 1
Lipid metabolism in the liver.
Canbay A, Bechmann L, Gerken G. Canbay A, et al. Among authors: gerken g. Z Gastroenterol. 2007 Jan;45(1):35-41. doi: 10.1055/s-2006-927368. Z Gastroenterol. 2007. PMID: 17236119 Review.
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX, Kang YK, Yen CJ, Finn RS, Galle PR, Llovet JM, Assenat E, Brandi G, Pracht M, Lim HY, Rau KM, Motomura K, Ohno I, Merle P, Daniele B, Shin DB, Gerken G, Borg C, Hiriart JB, Okusaka T, Morimoto M, Hsu Y, Abada PB, Kudo M; REACH-2 study investigators. Zhu AX, et al. Among authors: gerken g. Lancet Oncol. 2019 Feb;20(2):282-296. doi: 10.1016/S1470-2045(18)30937-9. Epub 2019 Jan 18. Lancet Oncol. 2019. PMID: 30665869 Clinical Trial.
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.
Best J, Bechmann LP, Sowa JP, Sydor S, Dechêne A, Pflanz K, Bedreli S, Schotten C, Geier A, Berg T, Fischer J, Vogel A, Bantel H, Weinmann A, Schattenberg JM, Huber Y, Wege H, von Felden J, Schulze K, Bettinger D, Thimme R, Sinner F, Schütte K, Weiss KH, Toyoda H, Yasuda S, Kumada T, Berhane S, Wichert M, Heider D, Gerken G, Johnson P, Canbay A. Best J, et al. Among authors: gerken g. Clin Gastroenterol Hepatol. 2020 Mar;18(3):728-735.e4. doi: 10.1016/j.cgh.2019.11.012. Epub 2019 Nov 8. Clin Gastroenterol Hepatol. 2020. PMID: 31712073 Free article.
[Hepatic encephalopathy].
Hilgard P, Gerken G. Hilgard P, et al. Among authors: gerken g. Med Klin (Munich). 2004 Oct 15;99(10):591-602. doi: 10.1007/s00063-004-1090-x. Med Klin (Munich). 2004. PMID: 15490075 Review. German.
Tivantinib for the treatment of hepatocellular carcinoma.
Best J, Schotten C, Lohmann G, Gerken G, Dechêne A. Best J, et al. Among authors: gerken g. Expert Opin Pharmacother. 2017 May;18(7):727-733. doi: 10.1080/14656566.2017.1316376. Epub 2017 Apr 17. Expert Opin Pharmacother. 2017. PMID: 28414564 Review.
[Living donor liver transplantation].
Broelsch CE, Malago M, Frilling A, Nadalin S, Malamutmann E, Klein C, Gerken G. Broelsch CE, et al. Among authors: gerken g. Chirurg. 2008 Feb;79(2):135-43. doi: 10.1007/s00104-007-1461-y. Chirurg. 2008. PMID: 18209984 Review. German.
Novel implications in the treatment of hepatocellular carcinoma.
Best J, Schotten C, Theysohn JM, Wetter A, Müller S, Radünz S, Schulze M, Canbay A, Dechêne A, Gerken G. Best J, et al. Among authors: gerken g. Ann Gastroenterol. 2017;30(1):23-32. doi: 10.20524/aog.2016.0092. Epub 2016 Sep 30. Ann Gastroenterol. 2017. PMID: 28042235 Free PMC article. Review.
[Liver parameters in intensive care medicine].
Penndorf V, Saner F, Gerken G, Canbay A. Penndorf V, et al. Among authors: gerken g. Zentralbl Chir. 2013 Dec;138(6):636-42. doi: 10.1055/s-0031-1271601. Epub 2012 May 7. Zentralbl Chir. 2013. PMID: 22565500 Review. German.
655 results